Background
Consensus methods are increasingly being used to develop clinical guidelines which define key aspects of the quality of health care, particularly appropriate indications for interventions. This review is restricted to formal consensus methods in which the structure, process and output are explicit from the outset. Three main approaches have been used in the health field: the Delphi method, the nominal group technique (NGT) and the consensus development conference.
Objectives
• To identify the factors that affect the decisions that emerge from consensus development methods.
• To assess the implications of the findings for the development of clinical guidelines.
• To recommend further methodological research for improving the use of consensus development methods as a basis for guideline production.
Methods

Data sources
The majority of the literature reviewed was identified through searches of Medline, PsychLIT and the Social Science Citation Index and from reference lists in retrieved articles.
Study selection
A matrix of 15 cells was developed from three types of activity (planning, individual judgement, group interaction) and five components (questions, participants, information, method of structuring the interaction, method of synthesising individual judgements) involved in consensus development methods.
Six cells were selected for detailed review on the basis of three criteria: (1) importance to consensus decision-making in the health sector; (2) the amount and quality of the literature available; (3) the potential for offering practical guidance. For each of the six cells the review drew on the results of the principal general search. For some cells, further focused searches were undertaken.
In all, 177 primary research and review articles were selected.
Data extraction and synthesis
If substantial literature was available from the health sector, we paid little or no attention to evidence from other sectors. If few or no studies had been conducted in the health sector, we sought relevant evidence from other fields. We used a narrative approach, sometimes based around tables of results. The extent to which research support exists for any conclusion is indicated, although these should not necessarily be considered as a hierarchy: A = clear research evidence; B = limited supporting research evidence; C = experienced common-sense judgement.
Results and conclusions
Setting the task or question to be addressed
• Cues included in scenarios must be selected with care. As well as reviewing the relevant literature, clinicians in the consensus group should give their opinions (most usefully in the first round) about which cues are important. Doing so may help maintain their participation and help them justify their judgements.
[C] • Contextual cues included in scenarios are as important as ones specific to the topic at issue, and they should be made explicit.
[B] • It must be decided whether to focus on ways of managing a specific condition or on indications for using an intervention. If the focus is on an intervention, care should be taken about how to deal with other relevant interventions.
[C] • Is a global judgement elicited, or is an attempt made to break the judgement down into probability and utility estimates? Although there are theoretical advantages to the latter, it is likely to be a more difficult task for participants and it may not enhance judgements.
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